NHS Framework for the North of England, Branded Medicine
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02e10332014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
40
4 SME
Lots
5
40 awarded
Published
01 Mar 2022
Total lots
5
Awarded
5
0 pending
Estimated total
—
Awarded total
—
Lot 1cancelled
CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B
Award value
—
Start
01 Mar 2022
End
29 Feb 2024
Estimated
—
CPV
33600000
Awarded to 18 suppliers
BI
IP
Lot 2cancelled
CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual Tranche
Award value
—
Start
01 Mar 2022
End
28 Feb 2023
Estimated
—
CPV
33600000
Awarded to 19 suppliers
Lot 3cancelled
CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE
Award value
—
Start
01 Mar 2022
End
31 Aug 2022
Estimated
—
CPV
33600000
Awarded to 1 supplier
Lot 4cancelled
CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London
Award value
—
Start
01 Mar 2022
End
31 Aug 2023
Estimated
—
CPV
33600000
Awarded to 1 supplier
Lot 5cancelled
CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE
Award value
—
Start
01 Mar 2022
End
28 Feb 2023
Estimated
—
CPV
33600000
Awarded to 1 supplier